Cancer Research UK, a charity from Great Britain, has awarded researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital a total of $50 million to continue their research into finding a cure for certain types of cancer.
Dana-Farber Cancer Institute’s Matthew Meyerson, M.D., PhD and Wendy Garrett, M.D., PhD, also of the Harvard T.H. Chan School of Public Health, received funding for their research into understanding how certain microbiomes lead to colorectal cancer and how the microbiomes can be manipulated to treat cancer.
Stephen Elledge, PhD, of Brigham and Women’s Hospital and Harvard Medical School, received funding for his studies into why genetic faults only affect certain tissues. He is working with collaborators from the US, the UK, and the Netherlands and his project is supported in partnership with The Mark Foundation for Cancer Research.